Chemical Works of Gedeon Richter (FRA:RIG2) Net Income From Continuing Operations : €392 Mil (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Chemical Works of Gedeon Richter Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Chemical Works of Gedeon Richter's net income from continuing operations for the three months ended in Mar. 2025 was €205 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was €392 Mil.

Chemical Works of Gedeon Richter Net Income From Continuing Operations Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Net Income From Continuing Operations Chart

Chemical Works of Gedeon Richter Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

288.41

367.07

414.87

429.59

703.90

Chemical Works of Gedeon Richter Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															103.41	206.03	186.22	-	205.30

Chemical Works of Gedeon Richter Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €392 Mil.

Chemical Works of Gedeon Richter Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (FRA:RIG2) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

RICHTER:Hungary 0QFP:UK

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.gedeonrichter.com/hu-hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.

Chemical Works of Gedeon Richter Headlines

No Headlines